NCT00940823View on ClinicalTrials.gov

The AVB Study: Prospective Study Comparing the Ahmed Valve and the Baerveldt Implant for Treating Refractory Glaucoma

NACompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2015

Conditions
Glaucoma
Interventions
DEVICE

Ahmed FP7 Valve

Implantation of Ahmed FP7 Valve to lower intraocular pressure in refractory glaucoma.

DEVICE

Baerveldt-350 Tube

Implantation of Baerveldt-350 Tube to lower intraocular pressure in refractory glaucoma.

Trial Locations (6)

37232

Vanderbilt Eye Institute, Nashville

46202

Eugene and Marilyn Glick Eye Institute, Indianapolis

53226

Drs. Massaro and Kalenak, Milwaukee

L5L 1W8

Credit ValleyEC, Toronto

H1V 1G5

Montreal Glaucoma Institute, Montreal

Unknown

Clinic of Las Condes, Santiago

All Listed Sponsors
collaborator

Glaucoma Research Society of Canada

OTHER

lead

Credit Valley EyeCare

INDUSTRY

NCT00940823 - The AVB Study: Prospective Study Comparing the Ahmed Valve and the Baerveldt Implant for Treating Refractory Glaucoma | Biotech Hunter | Biotech Hunter